BR112020018354A2 - Aumento de fornecimento gênico específico a tecido através de modificação de capsídeo - Google Patents
Aumento de fornecimento gênico específico a tecido através de modificação de capsídeo Download PDFInfo
- Publication number
- BR112020018354A2 BR112020018354A2 BR112020018354-7A BR112020018354A BR112020018354A2 BR 112020018354 A2 BR112020018354 A2 BR 112020018354A2 BR 112020018354 A BR112020018354 A BR 112020018354A BR 112020018354 A2 BR112020018354 A2 BR 112020018354A2
- Authority
- BR
- Brazil
- Prior art keywords
- modified
- aavrh74
- polynucleotide
- protein
- viral particle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14145—Special targeting system for viral vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862644317P | 2018-03-16 | 2018-03-16 | |
| US62/644,317 | 2018-03-16 | ||
| PCT/US2019/022353 WO2019178412A1 (en) | 2018-03-16 | 2019-03-14 | Increasing tissue specific gene delivery by capsid modification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112020018354A2 true BR112020018354A2 (pt) | 2020-12-29 |
Family
ID=67906893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020018354-7A BR112020018354A2 (pt) | 2018-03-16 | 2019-03-14 | Aumento de fornecimento gênico específico a tecido através de modificação de capsídeo |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12385062B2 (https=) |
| EP (1) | EP3765624A4 (https=) |
| JP (3) | JP7304878B2 (https=) |
| KR (3) | KR20250111395A (https=) |
| CN (2) | CN111819286B (https=) |
| AU (2) | AU2019234918C1 (https=) |
| BR (1) | BR112020018354A2 (https=) |
| CA (3) | CA3293599A1 (https=) |
| IL (2) | IL317905A (https=) |
| SG (1) | SG11202008687XA (https=) |
| WO (1) | WO2019178412A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2865487T3 (es) | 2015-09-28 | 2021-10-15 | Univ North Carolina Chapel Hill | Métodos y composiciones para vectores virales que evaden los anticuerpos |
| EP3765624A4 (en) * | 2018-03-16 | 2022-05-25 | Research Institute at Nationwide Children's Hospital | Increasing tissue specific gene delivery by capsid modification |
| EP3774852A1 (en) | 2018-04-03 | 2021-02-17 | Stridebio, Inc. | Antibody-evading virus vectors |
| MX2020010465A (es) | 2018-04-03 | 2021-01-08 | Vectores de virus para direccionamiento a tejidos oftalmicos. | |
| AU2019247748A1 (en) | 2018-04-03 | 2020-10-08 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
| AR118465A1 (es) | 2019-03-21 | 2021-10-06 | Stridebio Inc | Vectores de virus adenoasociados recombinantes |
| US12611436B2 (en) | 2019-10-17 | 2026-04-28 | Sarepta Therapeutics, Inc. | AAV transfer cassette |
| JP2022551739A (ja) | 2019-10-17 | 2022-12-13 | ストライドバイオ，インコーポレイテッド | ニーマン・ピック病ｃ型の治療のためのアデノ随伴ウイルスベクター |
| AU2021328475A1 (en) | 2020-08-19 | 2023-03-16 | Sarepta Therapeutics, Inc. | Adeno-associated virus vectors for treatment of Rett syndrome |
| US20240299586A1 (en) * | 2021-05-06 | 2024-09-12 | The Regents Of The University Of California | Novel aav serotypes derived from a library screen |
| WO2023196862A1 (en) | 2022-04-06 | 2023-10-12 | Genzyme Corporation | Targeted gene therapy for dm-1 myotonic dystrophy |
| US20240384271A1 (en) * | 2023-04-05 | 2024-11-21 | Genzyme Corporation | Targeted gene therapy for dm-1 myotonic dystrophy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846782A (en) * | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| EP2345731B1 (en) * | 2003-09-30 | 2015-10-21 | The Trustees of the University of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| WO2012109570A1 (en) | 2011-02-10 | 2012-08-16 | The University Of North Carolina At Chapel Hill | Viral vectors with modified transduction profiles and methods of making and using the same |
| NZ701693A (en) * | 2012-04-18 | 2017-02-24 | The Children’S Hospital Of Philadelphia | Composition and methods for highly efficient gene transfer using aav capsid variants |
| IL297919A (en) * | 2013-07-22 | 2023-01-01 | Childrens Hospital Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| GB201403684D0 (en) * | 2014-03-03 | 2014-04-16 | King S College London | Vector |
| CN107073051B (zh) * | 2014-10-21 | 2021-08-24 | 马萨诸塞大学 | 重组aav变体及其用途 |
| ES2865487T3 (es) * | 2015-09-28 | 2021-10-15 | Univ North Carolina Chapel Hill | Métodos y composiciones para vectores virales que evaden los anticuerpos |
| ES2977730T3 (es) * | 2016-04-15 | 2024-08-29 | Res Inst Nationwide Childrens Hospital | Administración de microARN-29 y micro-distrofina por virus adenoasociado para tratar la distrofia muscular |
| US11364308B2 (en) * | 2016-05-13 | 2022-06-21 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and methods of use thereof |
| EP3765624A4 (en) * | 2018-03-16 | 2022-05-25 | Research Institute at Nationwide Children's Hospital | Increasing tissue specific gene delivery by capsid modification |
| BR112021003174A2 (pt) * | 2018-08-30 | 2021-05-11 | Research Institute At Nationwide Children's Hospital | terapia gênica para o tratamento de galactosemia |
-
2019
- 2019-03-14 EP EP19768552.2A patent/EP3765624A4/en active Pending
- 2019-03-14 US US16/980,821 patent/US12385062B2/en active Active
- 2019-03-14 CA CA3293599A patent/CA3293599A1/en active Pending
- 2019-03-14 KR KR1020257023347A patent/KR20250111395A/ko active Pending
- 2019-03-14 JP JP2020548674A patent/JP7304878B2/ja active Active
- 2019-03-14 CA CA3293598A patent/CA3293598A1/en active Pending
- 2019-03-14 WO PCT/US2019/022353 patent/WO2019178412A1/en not_active Ceased
- 2019-03-14 KR KR1020257023337A patent/KR20250111393A/ko active Pending
- 2019-03-14 CA CA3092353A patent/CA3092353A1/en active Pending
- 2019-03-14 IL IL317905A patent/IL317905A/en unknown
- 2019-03-14 BR BR112020018354-7A patent/BR112020018354A2/pt unknown
- 2019-03-14 CN CN201980018151.0A patent/CN111819286B/zh active Active
- 2019-03-14 CN CN202410503648.4A patent/CN118373887A/zh active Pending
- 2019-03-14 SG SG11202008687XA patent/SG11202008687XA/en unknown
- 2019-03-14 IL IL277270A patent/IL277270B2/en unknown
- 2019-03-14 KR KR1020207028750A patent/KR102834868B1/ko active Active
- 2019-03-14 AU AU2019234918A patent/AU2019234918C1/en active Active
-
2023
- 2023-06-27 JP JP2023104920A patent/JP2023115149A/ja active Pending
-
2024
- 2024-07-23 JP JP2024117744A patent/JP2024144521A/ja active Pending
-
2025
- 2025-06-09 AU AU2025204275A patent/AU2025204275A1/en active Pending
- 2025-07-23 US US19/277,998 patent/US20250346924A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL277270B1 (en) | 2025-01-01 |
| JP2023115149A (ja) | 2023-08-18 |
| US12385062B2 (en) | 2025-08-12 |
| KR20250111393A (ko) | 2025-07-22 |
| CN111819286A (zh) | 2020-10-23 |
| KR20200131843A (ko) | 2020-11-24 |
| IL277270B2 (en) | 2025-05-01 |
| EP3765624A4 (en) | 2022-05-25 |
| AU2025204275A1 (en) | 2025-07-03 |
| EP3765624A1 (en) | 2021-01-20 |
| IL317905A (en) | 2025-02-01 |
| CN118373887A (zh) | 2024-07-23 |
| KR20250111395A (ko) | 2025-07-22 |
| CA3092353A1 (en) | 2019-09-19 |
| IL277270A (en) | 2020-10-29 |
| RU2020131998A (ru) | 2022-04-18 |
| JP2024144521A (ja) | 2024-10-11 |
| JP2021515572A (ja) | 2021-06-24 |
| JP7304878B2 (ja) | 2023-07-07 |
| SG11202008687XA (en) | 2020-10-29 |
| AU2019234918B2 (en) | 2025-08-14 |
| US20210087584A1 (en) | 2021-03-25 |
| AU2019234918A1 (en) | 2020-09-17 |
| CN111819286B (zh) | 2024-05-24 |
| AU2019234918C1 (en) | 2026-03-05 |
| CA3293598A1 (en) | 2026-03-02 |
| US20250346924A1 (en) | 2025-11-13 |
| KR102834868B1 (ko) | 2025-07-17 |
| CA3293599A1 (en) | 2026-03-02 |
| WO2019178412A1 (en) | 2019-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250346924A1 (en) | Increasing tissue specific gene delivery by capsid modification | |
| US9938541B2 (en) | AAV variant | |
| US12534741B2 (en) | Compositions and methods for treatment of neurological disorders | |
| WO2022015788A1 (en) | Recombinant adeno-associated viral vectors for multipartite gene delivery | |
| WO2021092518A1 (en) | Transgene cassettes, aav vectors and aav viral vectors for the expression of human codon-optimized slc6a1 | |
| JP7788594B2 (ja) | 乳児バッテン病の治療のための髄腔内および静脈内組合せ遺伝子療法 | |
| Rajapaksha et al. | Adeno-associated virus (AAV)-mediated gene therapy for disorders of inherited and non-inherited origin | |
| EP4073087A1 (en) | Recombinant adeno-associated viral vector for gene delivery | |
| WO2024220719A1 (en) | Modified aav capsids for gene delivery | |
| RU2801217C2 (ru) | Повышение тканеспецифической доставки генов путем модификации капсида | |
| WO2023081683A1 (en) | Gene therapy for prader willi syndrome | |
| WO2024163335A2 (en) | Pten gene therapy vectors and uses thereof | |
| WO2023102406A1 (en) | Vector genome design to express optimized cln7 transgene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |